IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,482,647 | -5.2% | 1,134,979 | -14.2% | 0.06% | -1.6% |
| Q2 2023 | $54,284,002 | -7.3% | 1,323,032 | -19.3% | 0.06% | -8.8% |
| Q1 2023 | $58,575,808 | -12.9% | 1,638,943 | -8.0% | 0.07% | -15.0% |
| Q4 2022 | $67,263,874 | -26.8% | 1,780,933 | -14.3% | 0.08% | -32.8% |
| Q3 2022 | $91,877,000 | +55.5% | 2,077,260 | +30.1% | 0.12% | +63.0% |
| Q2 2022 | $59,086,000 | -1.3% | 1,596,055 | -1.3% | 0.07% | +19.7% |
| Q1 2022 | $59,867,000 | +17.1% | 1,616,290 | -3.8% | 0.06% | +22.0% |
| Q4 2021 | $51,123,000 | -9.3% | 1,680,012 | -0.0% | 0.05% | -18.0% |
| Q3 2021 | $56,366,000 | -7.2% | 1,680,549 | +10.4% | 0.06% | -7.6% |
| Q2 2021 | $60,730,000 | +15.7% | 1,522,449 | +30.4% | 0.07% | +3.1% |
| Q1 2021 | $52,505,000 | -33.0% | 1,167,809 | -15.8% | 0.06% | -38.5% |
| Q4 2020 | $78,417,000 | +18.2% | 1,386,931 | -0.8% | 0.10% | -1.9% |
| Q3 2020 | $66,321,000 | -14.5% | 1,397,713 | +6.3% | 0.11% | -20.9% |
| Q2 2020 | $77,545,000 | +72.2% | 1,315,207 | +38.1% | 0.13% | +31.4% |
| Q1 2020 | $45,033,000 | -25.4% | 952,473 | -4.7% | 0.10% | -1.0% |
| Q4 2019 | $60,354,000 | +1.9% | 999,078 | +1.0% | 0.10% | -8.0% |
| Q3 2019 | $59,246,000 | -45.4% | 988,916 | -41.4% | 0.11% | -45.4% |
| Q2 2019 | $108,505,000 | -48.4% | 1,688,275 | -34.9% | 0.20% | -51.0% |
| Q1 2019 | $210,380,000 | +75.2% | 2,591,839 | +16.7% | 0.42% | +46.7% |
| Q4 2018 | $120,060,000 | +9.5% | 2,220,862 | +4.5% | 0.28% | +39.7% |
| Q3 2018 | $109,645,000 | +146.4% | 2,125,724 | +99.1% | 0.20% | +121.7% |
| Q2 2018 | $44,494,000 | -1.8% | 1,067,764 | +3.8% | 0.09% | -11.5% |
| Q1 2018 | $45,328,000 | -3.3% | 1,028,312 | +10.3% | 0.10% | -7.1% |
| Q4 2017 | $46,881,000 | -5.9% | 932,021 | -5.1% | 0.11% | -12.5% |
| Q3 2017 | $49,805,000 | +39.7% | 982,344 | +40.2% | 0.13% | +34.7% |
| Q2 2017 | $35,640,000 | +32.1% | 700,611 | +4.4% | 0.10% | +26.7% |
| Q1 2017 | $26,972,000 | -40.6% | 670,956 | -29.4% | 0.08% | -44.4% |
| Q4 2016 | $45,431,000 | +24.6% | 949,834 | -4.5% | 0.14% | +23.9% |
| Q3 2016 | $36,460,000 | +131.7% | 995,094 | +47.3% | 0.11% | +118.0% |
| Q2 2016 | $15,738,000 | -64.4% | 675,726 | -38.1% | 0.05% | -64.8% |
| Q1 2016 | $44,214,000 | -69.3% | 1,091,692 | -53.1% | 0.14% | -62.0% |
| Q4 2015 | $144,141,000 | – | 2,327,482 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |